Page last updated: 2024-09-05

sb 203580 and Multiple Organ Failure

sb 203580 has been researched along with Multiple Organ Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biffl, WL; Carnaggio, R; Ciesla, DJ; Johnson, JL; Moore, EE; Silliman, CC1
Jing, XL; Le, S; Liang, YB; Ma, ZF; Tang, H; Zhan, H1

Other Studies

2 other study(ies) available for sb 203580 and Multiple Organ Failure

ArticleYear
Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation.
    Surgery, 2003, Volume: 134, Issue:1

    Topics: Apoptosis; Blood Preservation; Caspase 3; Caspase Inhibitors; Caspases; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; In Vitro Techniques; Lysophosphatidylcholines; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophils; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Pyridines; Saline Solution, Hypertonic

2003
[Protective effect of p38 mitogen activated protein kinase inhibitor on organs in sepsis in rats].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2005, Volume: 17, Issue:4

    Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Imidazoles; Interleukin-1beta; Male; Multiple Organ Failure; p38 Mitogen-Activated Protein Kinases; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha

2005